Home
> GSK
GSK
Despite Profit Fallout, GSK Remains Optimist For 2031 Revenue Target Amidst Cancer Drug Sale Rise
GSK's oncology sales increased 98% in 2024, and reflects strong demand and potentially new launches or indications for cancer therapies.
Teddy Cambosa Feb 07, 2025
Chemical engineer fired for racist, homophobic rant onboard flight
A man hurled racist and homophobic abuse at a fellow passenger onboard an American Airlines flight from Philadelphia to Dallas.
Sadhna Yadav Sep 05, 2022
Coronavirus vaccine candidates from GlaxoSmithKline, Sanofi begin clinical trials
As with other vaccine candidates, if the outcome of the first two phases is acceptable, the final phase might be scheduled before the end of 2020.
John Diente Sep 04, 2020
UK govt securing 60mn more doses of virus vaccine from two pharmaceutical firms
Once the coronavirus vaccine is approved for use, the British government plans to prioritise those in the social services and healthcare sectors.
John Diente Jul 30, 2020
GSK to sell Horlicks as it reviews UK manufacturing options
The 100-year old drink has fallen out of favour with modern British tastes.
Roger Baird Jul 19, 2017
Weak pound boosts GSK first quarter revenue but company warns of generic competition
Drug-making giant beats forecast after reporting 19% year-on-year increase in Q1 revenue.
Dan Cancian Apr 26, 2017
Davos 2017: GSK chief says weak pound has been a boost and wants more transparency over drug pricing
GlaxoSmithKline has benefitted from pound's sharp decline but new EU regulations could be a concern.
Dan Cancian Jan 19, 2017
GlaxoSmithKline's new asthma drug earns UK approval after price cut
While Nucala has a list price of £840 per dose, the price it will be sold to the NHS is confidential.
Kedar Grandhi Dec 01, 2016
GlaxoSmithKline seeks FDA approval for shingles vaccine
According to analysts, Shingrix has the potential to earn $1bn annually.
Kedar Grandhi Oct 24, 2016
UK pharmaceutical firms have weathered Brexit storms but face long-term challenges
Sector is seen as a safe haven but it faces increasing regulatory costs in the future.
Dan Cancian Aug 08, 2016
GlaxoSmithKline and Alphabet's Verily partner for development of bioelectronic medicines
The new company will enable research, development and commercialisation of bioelectronic medicines.
Kedar Grandhi Aug 01, 2016
Glaxo posts jump in profits on new drug sales
GlaxoSmithKline said development work on its new drug pipeline is starting to pay off
Roger Baird Jul 27, 2016
GSK to invest £275m in Britain in major boost to UK economy
FTSE 100 drug maker will invest across three different UK sites and create new jobs
Dan Cancian Jul 27, 2016
FTSE Moves: Top flight shares edge up after Bank of England eases capital buffers
Bank of England governor Mark Carney lifts markets after easing capital requirements for lenders.
Roger Baird Jul 05, 2016
GlaxoSmithKline gel developed from a mouthwash could save thousands of babies
The antiseptic gel called Umbipro was developed in partnership with the charity Save the Children.
Kedar Grandhi Apr 30, 2016
GlaxoSmithKline to share knowledge on cancer drugs to benefit poorer countries
The Brentford headquartered company to allow competitors access to its patent pool.
Kedar Grandhi Mar 28, 2016
GlaxoSmithKline CEO Sir Andrew Witty to step down earlier than expected in 2017
GSK chief executive will step down in March next year after bowing to pressure from shareholders.
Dan Cancian Mar 17, 2016
GlaxoSmithKline hit by £37m fine from CMA for breaching law on anticompetitive agreements
CMA sanctions £37m fine after GSK paid £50m to stifle competition on one of its drugs between 2001 and 2004.
Dan Cancian Feb 12, 2016
GlaxoSmithKline 300th anniversary: From small east London pharmacy to multinational giant
In 300 years, GSK has grown from a small pharmacy to a multinational corporation.
Alfred Joyner Nov 09, 2015
Malaria vaccine: Mosquirix gets positive appraisal from EU regulator ahead of WHO testing
RTS,S vaccine developed by GlaxoSmithKline gets positive EMA review and next goes to WHO for tests
Sean Martin Jul 24, 2015
British investigator linked to GSK Peter Humphrey released early from Chinese jail
Humphrey's two and a half year jail sentence cut by seven months.
Rachel Middleton Jun 09, 2015
Goldman Sachs calls for $37bn UK funding to develop new antibiotics
A British government-backed review released on Thursday (14 May) is seeking billions of dollars to fund the development of 15 new antibiotics to counter antibiotic resistance.
Adam Justice May 15, 2015
GlaxoSmithKline to drive Asian business from new Singapore headquarters
GSK plans to move into a new global headquarters for Asia, located in Singapore, in 2017.
M Rochan Mar 11, 2015
Novartis and GSK complete $20bn transactions to reform both firms
GSK and Novartis have completed several transactions totalling $20bn.
Sean Martin Mar 02, 2015
GSK profits down in 2014 after China bribery scandal
Drug firm GlaxoSmithKline paid £300m after being found guilty of bribery in China.
Nigel Wilson Feb 04, 2015
GlaxoSmithKline to lay off hundreds of US workers as part of £1bn cost-cutting drive
Company's Research Triangle Park site in North Carolina would be most affected with about 900 redundant jobs.
Jerin Mathew Dec 04, 2014
Apollo to Bid for All of GSK's Mature Drugs Worth Over $3bn
Other bidders are looking to acquire certain regional businesses.
Jerin Mathew Nov 14, 2014
Ebola Outbreak: GlaxoSmithKline Claims It Will Have Vaccine Within Two Months
Healthcare workers on the frontline will be offered initial stock of the vaccine.
Lianna Brinded Oct 22, 2014
Three Novartis Executives to Leave After Eli Lilly and GSK Deals
George Gunn, Brian McNamara and Andrin Oswald, members of Novartis executive committee, will leave firm.
Jerin Mathew Oct 08, 2014
RBS Confirms Chairman Sir Philip Hampton is Leaving for GlaxoSmithKline
Hampton will join GSK in January 2015 as a non-executive director before assuming chairman's role.
Lianna Brinded Sep 25, 2014
Pages
- 1
- 2
- NEXT

